Monitoring & Evaluation Study of Project ECHO for ILD

Status Enrolling by invitation

Clinical Trial Summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Clinical Trial Description

Project ECHO (Extension for Community Healthcare Outcomes) is a knowledge-sharing model to expand the capacity of the health care workforce so that more people can get high quality care for their health conditions in or near the communities where they live. The model brings specialty disease expertise to community providers through its hub-and-spoke networks. The model relies on videoconferencing to connect local providers in non-urban or underserved communities (spoke sites) with an interdisciplinary team of specialist providers at academic medical centers (hubs) during virtual "teleECHO" clinic sessions, which include brief educational lectures and case-based, experiential learning. It is a guided, technology-enabled collaborative practice model in which community providers become experts in an area of community need within the scope of their practice, operating with increasing independence as their skills and self-efficacy grow. The model establishes meaningful, ongoing relationships with hub specialists who serve as telementors for spoke providers and relies on case-based learning from presentations of real-world de-identified patient cases. The overarching goal of the project is to implement and evaluate an adaptation of the ECHO model to interstitial lung disease (ILD) diagnosis and care among primary care physicians (PCPs) and community pulmonologists in non-urban or underserved communities. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05455437
Study type	Observational
Source	Pulmonary Care and Research Collaborative Limited
Contact
Status	Enrolling by invitation
Phase
Start date	July 2022
Completion date	March 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05828953` - Anlotinib Capsules in the Treatment for IPF/PF-ILDs	Phase 2/Phase 3
Active, not recruiting	`NCT02951416` - Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
Recruiting	`NCT00470327` - A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Completed	`NCT00512967` - The Occurence of Inflammation and Oxidative Stress in Lung Diseases	N/A
Completed	`NCT02689102` - Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD.	N/A
Completed	`NCT02796781` - Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases	Phase 1/Phase 2
Completed	`NCT00129701` - Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation	N/A
Recruiting	`NCT04855305` - Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease	Phase 2
Recruiting	`NCT01858259` - Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis	N/A
Recruiting	`NCT06068647` - Ultrasound and Respiratory Physiological Signals in Lung Diseases	N/A
Recruiting	`NCT01211015` - Endoplasmic Reticulum Stress in Chronic Respiratory Diseases	N/A
Recruiting	`NCT04370158` - Interstitial Lung Diseases Cohort Study in China
Enrolling by invitation	`NCT05727852` - Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Completed	`NCT02711657` - Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.	N/A
Active, not recruiting	`NCT00267800` - Database of Interstitial Lung Diseases	N/A
Completed	`NCT02763540` - Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD	N/A
Recruiting	`NCT06036719` - Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Completed	`NCT02549248` - Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology	N/A
Enrolling by invitation	`NCT02509364` - Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)	N/A
Completed	`NCT00741572` - Individual Sensitivity for Interstitial Lung Diseases	N/A

Monitoring and Evaluation Study of Project ECHO for ILD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms